Complete the form below to receive brochures and other educational materials about Aggrastat® for your clinic or hospital.
All Personal Information Will Be Kept Confidential And Will Not Be Shared With Any Parties Other Than Medicure And Its Designated Partners. Click Here To View Our Full Privacy Policy.
Indication:
Aggrastat® is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
Contraindications:
Warnings and Precautions:
Adverse Reactions:
For additional information, refer to the full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.FDA.gov/medwatch
or call 1-800-FDA-1088.